Details

Autor(en) / Beteiligte

• Bastiaenen, Rachel, PhD
• Cox, Andrew T., MRCP
• Castelletti, Silvia, MD
• Wijeyeratne, Yanushi D., MRCP
• Colbeck, Nicholas, MBBS
• Pakroo, Nadia, MBBS
• Ahmed, Hammad, MBBS
• Bunce, Nick, MD
• Anderson, Lisa, MD
• Moon, James C., MD
• Prasad, Sanjay, MD
• Sharma, Sanjay, MD
• Behr, Elijah R., MD

Titel

Late gadolinium enhancement in Brugada syndrome: A marker for subtle underlying cardiomyopathy?

Ist Teil von

• Heart rhythm, 2017-04, Vol.14 (4), p.583-589

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2017

Quelle

MEDLINE

Beschreibungen/Notizen

• Background There is increasing evidence that the Brugada ECG pattern is a marker of subtle structural heart disease. Objective We characterised Brugada syndrome (BrS) patients using cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE). Methods BrS was diagnosed according to international guidelines. 26% BrS patients carried SCN5A mutations. CMR data from 78 BrS patients were compared with 78 healthy controls (44±15 vs 42±14 years; p=0.434 and 64% vs 64% male; p=1.000). Results Right ventricular (RV) ejection fraction was slightly lower (61±8% vs 64±5%; p=0.004) and RV end-systolic volume slightly greater (31±10mL/m2 vs 28±6mL/m2 ; p=0.038) in BrS compared with controls. These values remained within the normal range. LGE was demonstrated in 8% BrS patients (left ventricular (LV) midwall LGE in 5%) but not in controls (p=0.028). In BrS patients with midwall LGE there were no other features of cardiomyopathy at the time of CMR but genetic testing and follow-up has revealed a desmoplakin mutation in one patient and evolution of T-wave inversion throughout all precordial ECG leads in another. Neither patient fulfils diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy. Conclusion Some BrS patients have LV midwall LGE consistent with an underlying cardiomyopathic process. Even cases without LGE show greater RV volumes and reduced RV function. These findings lend further support to the presence of subtle structural abnormalities in BrS. The BrS pattern with LGE may serve as early markers for evolution of a cardiomyopathic phenotype over time. CMR is a potentially useful adjunct investigation in the clinical evaluation of BrS.